Artal Group S.A. Krystal Biotech, Inc. Transaction History

Artal Group S.A.

$214 Million
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$78.48 - $130.32 $4.9 Million - $8.13 Million	-62,413 Reduced 15.15%	349,669 $41.1 Million
Q1 2023 May 12, 2023	BUY	$72.39 - $84.27 $874,615 - $1.02 Million	12,082 Added 3.02%	412,082 $33 Million
Q4 2022 Feb 13, 2023	SELL	$63.14 - $79.9 $6.31 Million - $7.99 Million	-100,000 Reduced 20.0%	400,000 $31.7 Million
Q1 2022 May 12, 2022	SELL	$51.99 - $72.11 $10.4 Million - $14.4 Million	-200,000 Reduced 28.57%	500,000 $33.3 Million
Q4 2021 Feb 11, 2022	BUY	$39.81 - $88.24 $7.96 Million - $17.6 Million	200,000 Added 40.0%	700,000 $49 Million
Q1 2021 May 14, 2021	BUY	$59.42 - $85.46 $15.6 Million - $22.4 Million	262,500 Added 110.53%	500,000 $38.5 Million
Q3 2020 Nov 13, 2020	BUY	$37.76 - $48.49 $1.42 Million - $1.82 Million	37,500 Added 18.75%	237,500 $10.2 Million
Q2 2020 Aug 14, 2020	BUY	$37.03 - $60.0 $3.7 Million - $6 Million	100,000 Added 100.0%	200,000 $8.28 Million
Q1 2020 May 14, 2020	BUY	$35.02 - $65.64 $700,400 - $1.31 Million	20,000 Added 25.0%	100,000 $4.32 Million
Q4 2019 Feb 13, 2020	SELL	$33.17 - $65.23 $2.32 Million - $4.57 Million	-70,000 Reduced 46.67%	80,000 $4.43 Million
Q3 2019 Nov 14, 2019	SELL	$34.72 - $51.3 $5.21 Million - $7.7 Million	-150,000 Reduced 50.0%	150,000 $5.21 Million
Q1 2019 May 10, 2019	BUY	$19.86 - $32.9 $496,500 - $822,500	25,000 Added 9.09%	300,000 $9.87 Million
Q4 2018 Feb 11, 2019	BUY	$15.03 - $25.38 $1.88 Million - $3.17 Million	125,000 Added 83.33%	275,000 $5.72 Million
Q4 2017 Feb 09, 2018	BUY	$8.19 - $11.19 $409,500 - $559,500	50,000 Added 50.0%	150,000 $1.58 Million
Q3 2017 Nov 08, 2017	BUY	$9.75 - $10.64 $975,000 - $1.06 Million	100,000	100,000 $997,000

Others Institutions Holding KRYS

# of Institutions

310

Shares Held

24.4M

Call Options Held

483K

Put Options Held

364K

Black Rock Inc. New York, NY

3.95M
Shares

$703 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

2.85M
Shares

$508 Million
0.01% of portfolio
Avoro Capital Advisors LLC New York, NY

2.62M
Shares

$467 Million
7.18% of portfolio
State Street Corp Boston, MA

1.45M
Shares

$259 Million
0.01% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

988K
Shares

$176 Million
9.67% of portfolio

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.57B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

News

Stay updated on Artal Group S.A. with notifications on news.

Account